Effects of gene therapy on CNS/PNS demyelination in metachromatic leukodystrophy

Research presented at EAN 2020 suggests that lentiviral hematopoietic stem and progenitor cell gene therapy (HSPC-GT) may prevent or halt demyelination and brain atrophy in late infantile disease.

Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.